(Q28277030)

1

0 references

S Tamura

2

0 references

E Buchdunger

3

0 references

S Ohno

4

0 references

G M Segal

5

0 references

S Fanning

6

0 references

J Zimmermann

7

0 references

N B Lydon

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

8

0 references

language of work or name

English

0 references

publication date

May 1996

0 references

published in

Nature Medicine

0 references

volume

2

0 references

issue

5

0 references

page(s)

561-6

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/NM0596-561

Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Autografting in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Current approaches to hematopoietic stem-cell purging in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL).

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

v-abl causes hematopoietic disease distinct from that caused by bcr-abl

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Tyrosine kinase inhibition: an approach to drug development

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

The nuclear tyrosine kinase c-Abl negatively regulates cell growth

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Lineage-specific requirement of c-abl function in normal hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Platelet-derived growth factor: mechanism of action and possible in vivo function

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features.

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Differentiation in erythroleukemic cells and their somatic hybrids

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

RETRACTED: 4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

cdc2 is a component of the M phase-specific histone H1 kinase: evidence for identity with MPF

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

A comparison of the response of human lung carcinoma xenografts to vindesine and vincristine

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021

Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0596-561

7 January 2021